Serina Therapeutics

#药闻简讯# 2025 年 11 月 3 日，处于临床阶段的生物技术公司$Serina Therapeutics(SER)$ 今天宣布，美国食品药品监督管理局（FDA）已对赛瑞纳公司 SER-252 新药研究申请（IND）实施临床暂停，SER-252 是赛瑞纳公司针对晚期帕金森病的领先开发项目。FDA 要求提供有关配方中常用赋形剂的额外信息。...

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000025  Size: 13 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001708599-25-000128  Size: 5 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000017  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001708599-25-000130  Act: 34  Size: 236 KB 网页链接

$Serina Therapeutics(SER)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001708599-25-000120  Act: 34  Size: 386 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000030  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000033  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000009  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000013  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001413350-25-000004  Size: 5 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000019  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001708599-25-000138  Act: 34  Size: 37 KB 网页链接

$Serina Therapeutics(SER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001708599-25-000133  Act: 34  Size: 6 MB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000021  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001267490-25-000003  Size: 5 KB 网页链接

$Serina Therapeutics(SER)$ 8-K Current report, item 8.01 Accession Number: 0001708599-25-000126  Act: 34  Size: 164 KB 网页链接

$Serina Therapeutics(SER)$ 144 Report of proposed sale of securities Accession Number: 0001972481-25-000246  Act: 33  Size: 10 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000007  Size: 8 KB 网页链接

$Serina Therapeutics(SER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001301120-25-000027  Size: 13 KB 网页链接